Gyrodyne, LLC current report, 04 May 2016

Business Context and Reporting Period

This Form 8-K Current Report was filed by Gyrodyne, LLC on May 4, 2016. The filing details the completion of a significant asset disposition by the Company's wholly-owned subsidiary, Virginia Healthcare Center, LLC (VHC).

Key Financial Metrics and Transaction Details

  • Asset Sale: VHC sold the Fairfax Medical Center in Fairfax, Virginia, to JAG Associates, L.L.C.
  • Purchase Price: $14,015,000.
  • Price Adjustment: The final price reflects a $300,000 reduction from the original agreement to allow the buyer to address specific property conditions.
  • Leaseback Obligation: VHC entered a master lease for 3,852 rentable square feet of vacant premises at a cost of $152,844 to meet occupancy requirements.
  • Guarantee: Gyrodyne, LLC guaranteed VHC's performance under the master lease, limited to two years of base rent.

Material Changes and Transaction Structure

The transaction involved a sale-leaseback structure. While the property was sold, VHC leased back specific vacant space to ensure the property met a pro forma occupancy level of 55,204 rentable square feet. The master lease is contingent; it will terminate if the leased premises are leased to third-party tenants. The Company expects prospective tenant interest to satisfy much, if not all, of this leaseback obligation.

Outlook, Risks, and Management Commentary

Management anticipates that the leaseback obligation will be minimized or eliminated through third-party leasing. The filing includes a forward-looking statement safe harbor, noting that actual results may differ due to risks inherent in the real estate markets of Suffolk County, New York, and Fairfax County, Virginia.

Investor Verification Checklist

  • Verify the final net proceeds from the $14,015,000 sale after closing costs and the $300,000 price reduction.
  • Monitor the status of the 3,852 square feet of leased-back space to determine if the $152,844 lease obligation will be incurred or avoided.
  • Review the impact of this asset disposition on the Company's overall liquidity and debt covenants.
  • Assess the Company's exposure to real estate market fluctuations in Virginia and New York as highlighted in the risk factors.